# Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY)

> **NCT01342939** · — · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 31 (actual)

## Conditions studied

- Maturity-onset Diabetes of the Young

## Interventions

- **OTHER:** Oral Glucose Tolerance Test (OGTT)
- **OTHER:** iso glycaemic intravenous (iv) glucose infusion (IIGI)
- **DIETARY_SUPPLEMENT:** Meal test
- **OTHER:** Sitagliptin
- **OTHER:** Incretin effect on sulphonyl urea treatment

## Key facts

- **NCT ID:** NCT01342939
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2013-01-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01342939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01342939, "Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY)". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT01342939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*